Resonance Health Ltd

Company Profile

• Business description

  Resonance Health Ltd is engaged in the development and commercialisation of software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. The Group’s core SaMD product is FerriScan, a non-invasive liver analysis technology used for the assessment of iron in the liver. The Company also has several AI-assisted SaMDs including FerriSmart, HepaFatSmart, and LiverSmart. Its business segments are; SaMD1 which derives key revenue, Corporate, TrialsWest, and Resonance Clinica. Geographically, it generates maximum revenue from the Asia Pacific region and the rest from North America, and Europe, Middle East and Africa (EMEA) regions.

• Contact

  141 Burswood Road
  Level 1
  Burswood
  PerthWA6100
  AUS

  T: +61 892865300

  https://www.resonancehealth.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Health Information Services

  Fiscal Year End

  30 June 2026

  Employees

  18